Pridopidine treatment benefits in definite, probable, and early (<18mo onset) subjects with ALS in the HEALEY ALS Platform Trial - Michal Geva; Y Paul Goldberg; Melanie L. Leitner; Kelly Chen; Wei Feng; Noga Gershoni Emek; James D. Berry; Sabrina Paganoni; Jeremy Shefner; Merit ECudkowicz; Michael R. Hayden (Neurotherapeutics)